1186194-07-9

Basic information

• Product Name: 3-(butylsulfonaMido)-2,6-difluorobenzoic acid
• Synonyms: 3-(butylsulfonaMido)-2,6-difluorobenzoic acid
• CAS NO: 1186194-07-9
• Molecular Formula: C₁₁H₁₃F₂NO₄S
• Molecular Weight: 293.2870264
• Mol File: 1186194-07-9.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-(butylsulfonaMido)-2,6-difluorobenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(butylsulfonaMido)-2,6-difluorobenzoic acid(1186194-07-9)
• EPA Substance Registry System: 3-(butylsulfonaMido)-2,6-difluorobenzoic acid(1186194-07-9)

Safety Data

• Hazardous Substances Data: 1186194-07-9(Hazardous Substances Data)

Relevant articles and documents

PROTEIN KINASE INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH

The invention relates to MKK4 (mitogen-activated protein kinase 4) and their use in promoting liver regeneration or reducing or preventing hepatocyte death. The MKK4 inhibitors selectively inhibit protein kinase MKK4 over protein kinases JNK and MKK7.

IMDIZO [4. 5-B] PYRIDINE DERIVATIVES USED AS RAF INHIBITORS

Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

PYRAZOLE [3, 4-B] PYRIDINE RAF INHIBITORS

Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers, tautomers, prodrugs and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.